Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - FREE CASH FLOW
Free Cash Flow ALNY - Alnylam Pharmaceuticals, Inc.
41.9 M
LAST VALUE
43.47%
2 YEAR CAGR
15.56%
5 YEAR CAGR
9.93%
10 YEAR CAGR